
|Articles|November 1, 2004
NMSC requires more aggressive screening, treatment, doctor says
Zurich - Although data on the incidence and prevalence of non-melanoma skin cancer (NMSC) remain limited, Dr. Rolf-Markus Szeimies of the department of dermatology, University of Regensburg Hospital, Germany, has compiled epidemiologic data demonstrating an increased incidence of actinic keratosis (AK), squamous cell carcinoma (SCC) and basal cell carcinoma (BCC).
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
Expert Panel Unanimously Backs DecisionDx-Melanoma for Guiding Personalized Cancer Care
4
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
5

















